PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, C/ Villarroel 170, 08036, Barcelona, Spain.\', \'Department of Microbiology, Hospital Clinic of Barcelona, Barcelona, Spain.\', \'University of Barcelona, Barcelona, Spain.\', \'Institute for Global Health (ISGlobal), Barcelona, Spain.\', \'Department of Pharmacy, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Medical Intensive Care Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Department of Internal Medicine, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Department of International Health, Hospital Clinic of Barcelona, Barcelona, Spain.\', \'Computer System Unit, Hospital Clinic, Barcelona, Spain.\', \'Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, C/ Villarroel 170, 08036, Barcelona, Spain. viladomiu@me.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-022-08882-x
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35347166
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35347166>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35347166>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all